Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein

Abstract

Most neutralizing antibodies against Middle East respiratory syndrome coronavirus (MERS-CoV) target the receptor-binding domain (RBD) of the spike glycoprotein and block its binding to the cellular receptor dipeptidyl peptidase 4 (DPP4). The epitopes and mechanisms of mAbs targeting non-RBD regions have not been well characterized yet. Here we report the monoclonal antibody 7D10 that binds to the N-terminal domain (NTD) of the spike glycoprotein and inhibits the cell entry of MERS-CoV with high potency. Structure determination and mutagenesis experiments reveal the epitope and critical residues on the NTD for 7D10 binding and neutralization. Further experiments indicate that the neutralization by 7D10 is not solely dependent on the inhibition of DPP4 binding, but also acts after viral cell attachment, inhibiting the pre-fusion to post-fusion conformational change of the spike. These properties give 7D10 a wide neutralization breadth and help explain its synergistic effects with several RBD-targeting antibodies.

Cited by papers we hold 10

• Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses · 2022
  Not checked
• Blockade of SARS-CoV-2 spike protein-mediated cell–cell fusion using COVID-19 convalescent plasma · 2021
  Not checked
• A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants · 2021
  Not checked
• Therapeutic approaches against coronaviruses acute respiratory syndrome · 2021
  Not checked
• A human coronavirus evolves antigenically to escape antibody immunity · 2021
  No notice
• A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 · 2020
  No notice
• Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition · 2020
  No notice
• Overview of lethal human coronaviruses · 2020
  No notice
• A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes · 2020
  No notice
• An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.